Literature DB >> 7989903

Incidence of pheochromocytoma in South Galicia, Spain.

L Fernández-Calvet1, R V García-Mayor.   

Abstract

OBJECTIVES: To estimate the incidence of pheochromocytoma in the population of South Galicia (Spain) during the period 1980-1992.
DESIGN: A prospective study.
SETTING: The General Hospital of Vigo, a tertiary referral centre.
SUBJECTS: New cases of pheochromocytoma diagnosed in the population during the years 1980-1992. The average population size was 523,934 inhabitants, (52% female, 48% male). MAIN OUTCOME MEASURES: All data were obtained from the Medical Registry, which ensures virtually complete case ascertainment for diagnosed pheochromocytoma in the population. All cases were histologically confirmed. The average annual incidence rate of pheochromocytoma was calculated.
RESULTS: For the study period, 14 new cases (eight female and six male) of pheochromocytoma were diagnosed in the population of South Galicia. The average annual incidence rate in the population was 2.06 (range 0.0-3.93) per million. This incidence rate was significantly higher in the female population (2.26 vs. 1.84; P < 0.05). The mean age at diagnosis was 43 +/- 12 (range 21-65) years. Thirteen of the 14 cases were diagnosed in living patients (two discovered incidentally at operation) and one case was diagnosed at autopsy. One pheochromocytoma was located outside the adrenals. All but one tumour were benign. One patient had pheochromocytoma as part of the multiple endocrine neoplasia type IIa, and in four patients it was associated with neurofibromatosis (28.57%). Four of the 13 patients surgically treated had residual hypertension.
CONCLUSIONS: The incidence of pheochromocytoma in our population is similar to that reported from other European countries. Routine screening for this disease is not recommended, but postoperative follow-up of the patients is needed. A wider study is necessary to confirm the high association with neurofibromatosis in our population.

Entities:  

Mesh:

Year:  1994        PMID: 7989903     DOI: 10.1111/j.1365-2796.1994.tb00861.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  9 in total

1.  Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.

Authors:  Irfan Jawed; Margarita Velarde; Roland Därr; Katherine I Wolf; Karen Adams; Aradhana M Venkatesan; Sanjeeve Balasubramaniam; Marianne S Poruchynsky; James C Reynolds; Karel Pacak; Tito Fojo
Journal:  Cell Mol Neurobiol       Date:  2018-04-05       Impact factor: 5.046

2.  High prevalence of eating disorders not otherwise specified in northwestern Spain: population-based study.

Authors:  Alejandra Larrañaga; María F Docet; Ricardo V García-Mayor
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-01-12       Impact factor: 4.328

Review 3.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

4.  Malignant abdominal paraganglioma presenting as a giant intra-peritoneal mass.

Authors:  Mohammad Kazem Moslemi; Maryam Abolhasani; Jamshid Vafaeimanesh
Journal:  Int J Surg Case Rep       Date:  2012-07-28

Review 5.  A Guide to Pheochromocytomas and Paragangliomas.

Authors:  Julie Guilmette; Peter M Sadow
Journal:  Surg Pathol Clin       Date:  2019-09-28

6.  A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma.

Authors:  Anna M Sawka; Ally PH Prebtani; Lehana Thabane; Amiram Gafni; Mitchell Levine; William F Young
Journal:  BMC Endocr Disord       Date:  2004-06-29       Impact factor: 2.763

7.  A retrospective study of surgically excised phaeochromocytomas in Newfoundland, Canada.

Authors:  Joanna Holland; Vikram Chandurkar
Journal:  Indian J Endocrinol Metab       Date:  2014-07

8.  Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years.

Authors:  Abdul Rahman Al Subhi; Veronica Boyle; Marianne S Elston
Journal:  J Endocr Soc       Date:  2022-07-03

9.  Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.

Authors:  Hui Huang; Jame Abraham; Elizabeth Hung; Steven Averbuch; Maria Merino; Seth M Steinberg; Karel Pacak; Tito Fojo
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.